Clonal background and routes of plasmid transmission underlie antimicrobial resistance features of bloodstream Klebsiella pneumoniae.
Odion O IkhimiukorNicole I Zac SolignoIfeoluwa J AkintayoMichael M MarcoviciStephanie S R SouzaAdrienne A WorkmanIsabella W MartinCheryl P AndamPublished in: Nature communications (2024)
Bloodstream infections caused by the opportunistic pathogen Klebsiella pneumoniae are associated with adverse health complications and high mortality rates. Antimicrobial resistance (AMR) limits available treatment options, thus exacerbating its public health and clinical burden. Here, we aim to elucidate the population structure of K. pneumoniae in bloodstream infections from a single medical center and the drivers that facilitate the dissemination of AMR. Analysis of 136 short-read genome sequences complemented with 12 long-read sequences shows the population consisting of 94 sequence types (STs) and 99 clonal groups, including globally distributed multidrug resistant and hypervirulent clones. In vitro antimicrobial susceptibility testing and in silico identification of AMR determinants reveal high concordance (90.44-100%) for aminoglycosides, beta-lactams, carbapenems, cephalosporins, quinolones, and sulfonamides. IncF plasmids mediate the clonal (within the same lineage) and horizontal (between lineages) transmission of the extended-spectrum beta-lactamase gene bla CTX-M-15 . Nearly identical plasmids are recovered from isolates over a span of two years indicating long-term persistence. The genetic determinants for hypervirulence are carried on plasmids exhibiting genomic rearrangement, loss, and/or truncation. Our findings highlight the importance of considering both the genetic background of host strains and the routes of plasmid transmission in understanding the spread of AMR in bloodstream infections.
Keyphrases
- klebsiella pneumoniae
- antimicrobial resistance
- escherichia coli
- multidrug resistant
- genome wide
- public health
- copy number
- drug resistant
- gram negative
- dna methylation
- risk factors
- acinetobacter baumannii
- healthcare
- crispr cas
- genetic diversity
- single molecule
- single cell
- mental health
- candida albicans
- cardiovascular events
- gene expression
- emergency department
- climate change
- coronary artery disease
- molecular docking
- transcription factor
- risk assessment
- cardiovascular disease
- pseudomonas aeruginosa
- human health